Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Cardio > Respiratory Tract Infections and Immunity > Flashcards

Respiratory Tract Infections and Immunity Flashcards

1
Q

What are the signs and symptoms of Upper respiratory tract infection

A

A cough
Sneezing
A runny or stuffy nose
A sore throat
Headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the signs and symptoms of Lower respiratory tract infection

A

A “productive” cough - phlegm
Muscle aches
Wheezing
Breathlessness
Fever
Fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is DALY – Disability-adjusted Life Year

A

A sum of Years of Life Lost (YLL) and Years Lost to Disability (YLP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the signs and symptoms of pneuomonia

A

Chest pain
Blue tinting of the lips
Severe fatigue
High Fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Does pneumonia increase with age?

A

Yes
More common in men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are risk factors for pneumonia?

A

Demographic and lifestyle factors
Age <2 years or >65 years
Cigarette smoking
Excess alcohol consumption

Social factors
Contact with children aged <15 years
Poverty
Overcrowding

Medications
Inhaled corticosteroids
Immunosuppresants (e.g steroids)
Proton pump inhibitors

Medical history
COPD, Asthma
Heart disease
Liver disease
Diabetes mellitus
HIV, Malignancy, Hyposplenism
Complement or Ig deficiencies
Risk factors for aspiration
Previous pneumonia

Specific risk factors for certain
pathogens
Geographical variations
Animal contact
Healthcare contacts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are common causative agents or respiratory infections?

A

Bacterial
Streptococcus pneumoniae
Myxoplasma pneumoniae
Haemophilus Influenzae

Mycobacterium tuberculosis

Viral
Influenza A or B virus
Respiratory Syncytial Virus
Human metapneumovirus
Human rhinovirus
Coronaviruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

A

Causative agent of coronavirus disease first observed in 2019 (COVID-19)
Asymptomatic <-> respiratory pneumonia and lung failure.
Up to November 2022

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Gives examples of Community acquired pneumonia (CAP)

A

Bacterial
Streptococcus pneumoniae (40-50%)
Myxoplasma pneumoniae
Staphylococcus aureus
Chlamydia pneumoniae
Haemophilus Influenzae

Examples of typical - Common
Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give examples of Hospital acquired pneumonia and Ventilator associated pneumonia

A

Hospital acquired pneumonia
Staphylococcus aureus
Psuedomonas aeruginosa
Klebsiella species
E. coli
Acinetobacter spp.
Enterobacter spp.

Ventilator associated pneumonia
Psuedomonas aeruginosa (25%)
Staphylococcus aureus(20%)
Enterobacter

Examples of atypical
Mycoplasma pneumoniae, Chlamydia pneumoniae,
Legionella pneumophilia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the mechanisms of damage for acute bacterial pneumonia***

A

Lung injury
Bacteraemia
Systemic inflammation
Treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Pneumonia

A

Inflammation and swelling of the alveoli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do you grade potential bacterial pneumonia?

A

CRB/CURB-65 scoring (1 point per item)
Confusion
Respiratory rate – >30 breaths/min
Blood pressure - < 90 systolic and/or 60 mmHg diastolic
65 - 65 years old or older

In hospital add
Urea - 7 mmol/L

0: Low severity - home treatment , antibiotics
1-2: Moderate severity = consider hospital treatment
3-4: High severity - urgent hospital admission , empirical antibiotics if life threatening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the treatments for bacteria pneumonia?

A

Supportive Therapy

Oxygen (for hypoxia)
Fluids (for dehydration)
Analgesia (for pain)
Nebulised saline (may help expectoration)
Chest physiotherapy?

Antibiotics
Penicillins e.g. amoxicillin – beta lactams that bind proteins in the bacterial cell wall to prevent transpeptidation

Macrolides e.g. clarithromycin – bind to the bacterial ribosome to prevent protein synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the specific antibiotics for treating CAP and HAP?***

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can you catch pneumonia?

A

Oropharynx
Strep. viridans
Coagulase neg. staph
Veronella
Fusiforms
Treponena spp.
Beta-haem. strep
Haemophilus spp.
Staph. aureus
Strep. pneumoniae

Nose
Coagulase neg. staph
Haemophilus spp.
Staph. aureus
Strep. viridans
Strep. pneumoniae

17
Q

What is the human microbiome

What is microbiota

What is commensal

A

100 trillion microbial cells populate our bodies at every barrier surface

Ecological communities of microbes found inside multi-cellular organisms

Microbes that live in a “symbiotic” relationship with their host. Providing vital nutrients to the host in the presence of a suitable ecological niche

18
Q

What is an opportunistic pathogen?

A

A microbe that takes advantage of a change in conditions (often immuno -suppressioWhn).

19
Q

What is a pathobiont

A

A microbe that is normally commensal, but if found in the wrong environment (e.g. anatomical site) can cause pathology.

20
Q

Why do viral infections results in disease

What does the damage to epithelium caused by viral infection do?

A

Mediator release
Cellular inflammation
Local immune memory

Loss of cilia
Bacterial growth
Poor barrier to antigen
Loss of chemoreceptors

21
Q

What can cause severe disease?

A
  1. Highly pathogenic strains (zoonotic)
  2. Absence of prior immunity
    Innate immunodeficiency (e.g. IFITM3 gene variant)
    B cells (antibody- presumably local)
    T cells (correlate with peripheral levels?)
  3. Predisposing illness/conditions
    Frail elderly
    COPD/asthma
    Diabetes, obesity, pregnancy etc.
22
Q

What is virus binding?

A

Most respiratory viruses can infect cells throughout the respiratory tract, but tend to preferentially adapt to bind cells of the upper respiratory tract if they have existed in humans for a prolonged time

23
Q

Where to viruses infect?

A

2009 - H1N1 influenza A
Haemogglutinin binds 𝛂2,6 sialic acids

2012 - H5N1 avian Flu
Haemogglutinin binds 𝛂2,3 sialic acids

2019 – SARS-CoV-2
Spike (S) protein binds Angiotensin converting enzyme 2 (ACE2)

24
Q

Explain how respiratory epithelium is the target and first line of defence?

A

Tight junctions – prevents systemic infection
Mucous lining and cilial clearance – prevents attachment, clears particulates
Antimicrobials – recognise, neutralise and/or degrade microbes and their products
Pathogen recognition receptors – recognise pathogens either outside or inside a cell
Interferon pathways – activated by viral infection. Promotes upregulation of anti-viral proteins and apoptosis.

25
Q

What are serotypes?

A

Viruses/pathogens which cannot be recognised by serum (really antibodies) that recognise another virus – implications for protective immunity

26
Q

What is Antibody mediated immunity

A

Humoral immunity
Adaptive, so dependent on prior exposure
B cells activated to differentiate into antibody secreting plasma cells
Different antibody classes provide different biochemical properties and functions

27
Q

Explain types of viral immunity

A

Antibody mediated immunity

Enriched for IgA
High frequency of IgA-plasma cells
ECs express poly IgA receptor, allowing export of IgA to the mucosal surface
Homodimer is extremely stable in protease rich environment

27
Q

Explain types of viral immunity

A

Antibody mediated immunity

Enriched for IgA
High frequency of IgA-plasma cells
ECs express poly IgA receptor, allowing export of IgA to the mucosal surface
Homodimer is extremely stable in protease rich environment

Enriched for IgGs
Thin-walled alveolar space allows transfer of plasma IgGs into the alveolar space

28
Q

Influenza vs RSV vs SARS-CoV-2

A

No re-infection by same strain

Imperfect vaccines:
Vaccine-induced immunity rapidly wanes
Mainly homotypic immunity
Annual vaccination required

Recurrent re-infection with similar strains

No vaccine
Poor immunogenicity
Vaccine-enhanced disease
Very active research field

No prior immunity

Newly licenced vaccine
Waning immunity
Potential for re-infection
Unclear what vaccination regime will be required

29
Q

What is the leading cause of infant hospitalisation in the developed world?

What are similar viruses at lower prevalence?

What are risk factors?

A

Bronchiolitis due to RSV

Similar viruses at lower prevalence include hMPV and PIV.

Premature birth
Congenital heart and lung disease

30
Q

What are treatments for SARS-CoV-2

A

Supportive Therapy

Oxygen (for hypoxia)
Fluids (for dehydration)
Analgesia (for pain)
Nebulised saline (may help expectoration)
Chest physiotherapy?

Preventative/prophylactic: Vaccines
Major surface antigen – spike protein
Viral vector (e.g. adenovirus vaccine e.g. Oxford/AZ)
mRNA vaccines (e.g. BioNtech/Pfizer)

Therapeutic: Anti inflammatory
Dexamethasone (steroids)
Tocilizumab (anti-IL-6R) or Sarilumab (anti-IL-6)

Anti-virals
Remdesivir – broad spectrum antiviral – blocks RNA-dependent RNA polymerase activity
Paxlovid – antiviral protease inhibitor
Casirivimab and imdevimab - monoclonal neutralising antibodies for SARS-CoV-2

31
Q

What are treatment options for RSV?

A

Vaccines
Monoclonal antibodies
Anti-virals

Cardio (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions